Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Targeting farnesyl pyrophosphate synthase of Trypanosoma cruzi by fragment-based lead discovery

Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas disease (CD), which mostly affects underprivileged populations in South and Central America. The current standard of care for this disease are the two empirically discovered drugs benznidazole and nifurtimox. They show low efficacy, diffi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Petrick, Joy Kristin
Outros Autores: Klebe, Gerhard (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Formato: Dissertation
Idioma:inglês
Publicado em: Philipps-Universität Marburg 2019
Assuntos:
Pharmakologie, Therapeutik
mevalonate
farnesyl pyrophosphate
kissing bug
Isoprenoid
FPPS
Fragment-basierte Wirkstoffforschung
FDPS
Chagas disease
Chagas
fragment based drug discovery
Protein-Kristallograph
protein cry
isoprenoid
Vernachlässigte Krankheit
Farnesylpyroposphate-Synthase
neglected disease
Pharmacology & therapeutics, prescription drugs
Acesso em linha:Texto integral em PDF
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

Texto integral em PDF

Detalhes do Exemplar
Área/Cota: urn:nbn:de:hebis:04-z2019-05018
Publikationsdatum: 2020-05-25
Datum der Annahme: 2019-09-12
Downloads: 74 (2024), 149 (2023), 183 (2022), 158 (2021), 49 (2020)
Lizenz: https://rightsstatements.org/vocab/InC-NC/1.0/
Zugangs-URL: https://archiv.ub.uni-marburg.de/diss/z2019/0501
https://doi.org/10.17192/z2019.0501

Registos relacionados